Endocannabinoids promote hepatic lipogenesis and steatosis through CB1 receptors

Hepatology

Volumn 42, Issue 4, 2005, Pages 959-961

  Schwabe, Robert F ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE 1; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; FATTY ACID SYNTHASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SREBP 1C; UNCLASSIFIED DRUG;

ANOREXIA; APPETITE; CONTROLLED STUDY; DIET; FATTY ACID SYNTHESIS; FATTY LIVER; FOOD INTAKE; GENE EXPRESSION; HYPOTHALAMUS; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; LIVER CELL; LIVER LEVEL; LIVER METABOLISM; METABOLIC REGULATION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 25844522802     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20900     Document Type: Note

References (18)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
2. Choudhury J, Sanyal AJ. Insulin resistance in NASH. Front Biosci 2005; 10:1520-1533.
3. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. HEPATOLOGY 2005;42:5-13.
4. Cai D, Yuan M, Frantz FF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005;11:183-190.
5. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005;11:191-198.
6. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda S, et al. A central role for JNK in obesity and insulin resistance. Nature 2002;420:333-336.
7. Mechoulam R. Cannabinoids as Therapeutic Agents. Boca Raton, FL: CRC Press, 1984.
8. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346:561-564.
9. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-65.
10. Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 2004;3:771-784.
11. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, et al. Leptin-regulated endocannabmoids are involved in maintaining food intake. Nature 2001;410:822-825.
12. Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubett M, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003;112:423-431.
13. Osei-Hyiaman D, Deperrillo M, Pacher P, Liu J, Radaeva S, Barkai S, et al. Endocannabinoid activation at hepatic CB(1) receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005; 115:1298-1305.
14. Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J, et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 2001;7:827-832.
15. Ros J, Claria J, To-Figueras J, Planaguma A, Cejudo-Martin P, Fernandez-Varo G, et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology. 2002;122:85-93.
16. Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenrerology 2005;128:742-755.
17. Siegmund SV, Uchinami H, Osawa Y, Brenner DA, Schwabe RF. Anandamide induces necrosis in primary hepatic stellate cells. HEPATOLOGY 2005;41:1085-1095.
18. Wang L, Liu J, Harvey-White J, Zinimmer A, Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A 2003;100:1393-1398.